Emergent Biosolutions Inc. · NYSE:EBS
Zoon Kathryn C sold 17,202 Emergent Biosolutions Inc. shares (Form 4)
Traded Apr 30 to May 1, 2026 · Filed May 4, 2026
From Apr 30 to May 1, 2026, Zoon Kathryn C (Director) sold 17,202 Emergent Biosolutions Inc. shares at an average US$8.40 for US$144K under a trading plan, leaving 79,941 shares. Filed May 4, 2026 (Form 4).
- Sold
- 17,202 shares
- Price
- US$8.40 average (US$8.36 to US$8.97)
- Value
- US$144K
- Holding after
- 79,941 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 30, 2026 | Common Stock | Award | 25,344 | 97,143 | Direct | |
| May 1, 2026 | Common Stock | Sale | 16,145 | US$8.36 | 80,998 | Direct |
| May 1, 2026 | Common Stock | Sale | 1,057 | US$8.97 | 79,941 | Direct |
Source
Related
- Emergent Biosolutions Inc.
- Zoon Kathryn C
- Emergent Biosolutions Inc. shareholders
- Form 4 · DeGolyer Donald W · Oct 7, 2026
- Form 4 · Williams Paul Anthony · Oct 5, 2026
- Schedule 13G · American Century Investment Management, Inc. · Aug 14, 2026
- Schedule 13G/A · Vanguard Capital Management LLC · Jul 31, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026